Offer
Provide additional details about the offer you're running.
This store requires javascript to be enabled for some features to work correctly.
We Kiwis are a pretty healthy bunch. According to results from the latest 2019/20 New Zealand Health survey undertaken by the Ministry of Health, 87% of adults self-reported they were in good health (Ministry of Health, 2020).
Whether our health is good or not, at some point in our lives we will all experience pain. More than likely we’ll require medication to alleviate the pain. In 2017 the New Zealand government announced a commitment to making medicinal cannabis more available for people with terminal illness and chronic pain. On 18 December 2018, the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 came into force. This Act allowed affordable access to medicinal cannabis for people in palliative care.
Our perception and acceptance of cannabis—and therefore hemp—are shifting. The evidence for this can be seen in:
Embroiled in the cannabis debate is cannabidiol (CBD). This is a naturally-occurring substance derived from the cannabis plant. It does not produce a “high” like marijuana but is thought to exert a profound therapeutic effect. People are talking: CBD can help with epilepsy, anxiety, sleeping, and pain relief. There’s a lot of hype around what it may do, some of which may be true. However, without the research to support these claims, a lot of questions remain.
To protect the New Zealand consumer our government has laws and regulations to safeguard against charlatans and ensure the medicines we purchase are quality medicinal products.
For a substance to be a medicine it must have a therapeutic effect. Therapeutic purpose is defined in the Medicines Act 1981 (New Zealand Legislation, 2014).
CBD used to be classed as a controlled drug and fell under the Misuse of Drugs Act 1975. However, when the government changed the law in 2018 to allow easier access to cannabis, it also changed the status of CBD to a medicine and so it now falls under the Medicines Act 1981.
The law defines three classification categories for medicines (Medsafe, 2019). These categories are known as the First Schedule (Medicines Regulations 1984: New Zealand Legislation, 2018):
CBD is classified as a prescription medicine. You cannot purchase it from a website, Facebook, or any source other than a pharmacy by prescription. If you are bringing it in from overseas you also need a prescription.
The 2018 change of industrial hemp legislation opened the door for individuals to take advantage of how the law was interpretated with respect to CBD. To comply with regulatory processing methods, when harvesting the hemp seed the farmer needs to ensure there is no contamination from other substances, such as CBD or THC. The seeds need to be washed before being cold pressed for oil.
To help us understand the relationship between hemp seed food and CBD, the Ministry for Primary Industries has stated (Ministry for Primary Industries, 2020):
This means any hemp product sold here in New Zealand and labelled ‘Cannabidiol oil’, ‘Full Spectrum Hempseed oil’ or containing ‘CBD’ oil will NOT have a therapeutic effect. If it does, it is a medicine and must be registered as such.
If you are buying products labelled this way, you’re probably being charged around $100-plus for less than 40ml—far too much for what is supposed to be hempseed oil. A 250ml bottle of hempseed oil will set you back about $20.
CBD is not unsafe but it’s not without risks.
Without sufficient scientific research to support the efficacy and the safety of CBD products we must rely on the expertise of our medical professionals to advise us. Businesses working within the New Zealand hemp industry must play by the rules—NOT with your health.
Check out our updated snack bar packaging – same great taste inside.